Y&R launches new global technology marketing practice
Y&R announced today that Y&R is launching a new global technology marketing practice named Tech.YR.
YM BioSciences Inc., a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development, today reported that nimotuzumab has been approved for marketing in Mexico .